Primary efficacy outcome
pain
The prespecified primary efficacy outcome was a clinically significant improvement in pain, measured as the percentage of patients with a decrease >40% in the score in the WOMAC pain subscale at the final visit with respect to baseline. This outcome was not presented in the published article but only in the unpublished final report.